These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30694866)

  • 21. Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
    Hagström H; Nasr P; Ekstedt M; Hammar U; Stål P; Hultcrantz R; Kechagias S
    J Hepatol; 2017 Dec; 67(6):1265-1273. PubMed ID: 28803953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
    Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
    Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of hepatic steatosis and fibrosis with heart failure and mortality.
    Park J; Kim G; Kim H; Lee J; Lee YB; Jin SM; Hur KY; Kim JH
    Cardiovasc Diabetol; 2021 Sep; 20(1):197. PubMed ID: 34583706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Van Natta ML; Clark J; Neuschwander-Tetri BA; Diehl A; Dasarathy S; Loomba R; Chalasani N; Kowdley K; Hameed B; Wilson LA; Yates KP; Belt P; Lazo M; Kleiner DE; Behling C; Tonascia J;
    N Engl J Med; 2021 Oct; 385(17):1559-1569. PubMed ID: 34670043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure.
    Valbusa F; Agnoletti D; Scala L; Grillo C; Arduini P; Bonapace S; Calabria S; Scaturro G; Mantovani A; Zoppini G; Turcato E; Maggioni AP; Arcaro G; Targher G
    Int J Cardiol; 2018 Aug; 265():162-168. PubMed ID: 29739707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of metabolic risk factors on hepatic and cardiac outcomes in patients with alcohol- and non-alcohol-related fatty liver disease.
    Lim J; Sang H; Kim HI
    JHEP Rep; 2023 Jun; 5(6):100721. PubMed ID: 37138675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.
    Joo SK; Kim W; Kim D; Kim JH; Oh S; Lee KL; Chang MS; Jung YJ; So YH; Lee MS; Bae JM; Kim BG
    Liver Int; 2018 Feb; 38(2):331-341. PubMed ID: 28796410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association between Advanced Liver Fibrosis and Mortality Is Modified by Dietary Quality among Korean Adults: Results from the Korea National Health and Nutrition Examination Survey with Mortality Data.
    Lee J; Jo G; Park D; Jun HJ; Bae JH; Shin MJ
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
    Sung KC; Seo DC; Lee SJ; Lee MY; Wild SH; Byrne CD
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):489-495. PubMed ID: 30940491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low heart rate variability from 10-s electrocardiograms is associated with development of non-alcoholic fatty liver disease.
    Choi IY; Chang Y; Kang G; Jung HS; Shin H; Wild SH; Byrne CD; Ryu S
    Sci Rep; 2022 Jan; 12(1):1062. PubMed ID: 35058515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study.
    Joo EJ; Chang Y; Yeom JS; Ryu S
    Hepatology; 2017 Mar; 65(3):828-835. PubMed ID: 28035771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Final results of a long-term, clinical follow-up in fatty liver patients.
    Dam-Larsen S; Becker U; Franzmann MB; Larsen K; Christoffersen P; Bendtsen F
    Scand J Gastroenterol; 2009; 44(10):1236-43. PubMed ID: 19670076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.
    Yang HJ; Chang Y; Park SK; Jung YS; Park JH; Park DI; Cho YK; Ryu S; Sohn CI
    Dig Dis Sci; 2017 Dec; 62(12):3605-3613. PubMed ID: 29063416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population.
    Pérez-Gutiérrez OZ; Hernández-Rocha C; Candia-Balboa RA; Arrese MA; Benítez C; Brizuela-Alcántara DC; Méndez-Sánchez N; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2013; 12(3):416-24. PubMed ID: 23619258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.
    Ito T; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Nishimura D; Toyoda H; Kumada T; Goto H; Hirooka Y
    J Gastroenterol Hepatol; 2019 Jan; 34(1):207-214. PubMed ID: 30144360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    Lee JM; Park YM; Yun JS; Ahn YB; Lee KM; Kim DB; Lee JM; Han K; Ko SH
    PLoS One; 2020; 15(1):e0226351. PubMed ID: 31978054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
    Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.
    Le MH; Devaki P; Ha NB; Jun DW; Te HS; Cheung RC; Nguyen MH
    PLoS One; 2017; 12(3):e0173499. PubMed ID: 28346543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.